588720-62-1 Usage
Uses
Used in Organic Synthesis:
Ethyl 6-bromoH-pyrrolo[1,2-a]pyrazine-3-carboxylate is used as a key intermediate in organic synthesis for the production of various chemical compounds. Its unique structure allows for versatile reactions and transformations, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Ethyl 6-bromoH-pyrrolo[1,2-a]pyrazine-3-carboxylate is used as a starting material or building block in the development of new drugs and pharmaceutical products. Its biological activity and potential therapeutic properties make it a promising candidate for the creation of innovative medications.
Used in Drug Development:
Ethyl 6-bromoH-pyrrolo[1,2-a]pyrazine-3-carboxylate is employed as a precursor in the synthesis of active pharmaceutical ingredients (APIs). Its unique chemical properties enable the design and synthesis of novel drug molecules with potential therapeutic benefits.
Used in Chemical Research:
Ethyl 6-bromoH-pyrrolo[1,2-a]pyrazine-3-carboxylate is also used in chemical research to study its properties, reactivity, and potential applications. Researchers utilize Ethyl 6-bromoH-pyrrolo[1,2-a]pyrazine-3-carboxylate to explore new reaction pathways, mechanisms, and the development of innovative synthetic methods.
Check Digit Verification of cas no
The CAS Registry Mumber 588720-62-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,8,8,7,2 and 0 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 588720-62:
(8*5)+(7*8)+(6*8)+(5*7)+(4*2)+(3*0)+(2*6)+(1*2)=201
201 % 10 = 1
So 588720-62-1 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2O2/c1-2-15-10(14)8-6-13-7(5-12-8)3-4-9(13)11/h3-6H,2H2,1H3
588720-62-1Relevant articles and documents
COMPOUNDS HAVING BOTH α7 NICOTINIC AGONIST ACTIVITY AND 5HT3 ANTAGONIST ACTIVITY FOR TREATMENT OF CNS DISEASES
-
Page 67, (2010/02/06)
The invention discloses compounds that are selective α7 nAChR agonists and 5-HT3 antagonists. The compounds are useful for treating many CNS diseases.
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the treatment of disease
-
Page 56, (2010/02/06)
The invention provides compounds of Formula I: 1These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat conditions or diseases in which α7 is known to be involved.
